Michael T. McCabe

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study”.

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861

N/A

1.9DataRank · unranked

62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Nature Cancer(2021)10.1038/s43018-021-00249-x

N/A

0DataRank · unranked

288 citations

Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell, Christian Sherk +57 more

Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors

Structure(2022)10.1016/j.str.2022.03.009

N/A

0DataRank · unranked

33 citations

Sarath Pathuri, Kristen Wong, Ren Ren, Lourdes Rueda, David T. Fosbenner +7 more

PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1671

N/A

0DataRank · unranked

33 citations

Sarah Warda, Jesper L.V. Mååg, Rohan Misra, Miguel A. Miranda-Román, Mohini R. Pachai +22 more

PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral Mimicry

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.28.493429

N/A

0DataRank · unranked

0 citations

Sarah Warda, Jesper L.V. Mååg, Rohan Misra, Miguel A. Miranda-Román, Mohini R. Pachai +20 more

A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation

Scientific Reports(2024)10.1038/s41598-024-77314-9

N/A

0DataRank · unranked

3 citations

Abolfazl Arab, Raymond Dai, Albertas Navickas, Lisa Fish, Kristle Garcia +10 more